Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-07-011311

10% owner bought 720,000,000 shares at $0.01 ($6,984,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trinad Capital Master Fund Ltd. 10% owner 2007-02-12 Purchase +360,000,000 $0.01 $3,492,000 429,750,000 D: show line 1 in the form
Trinad Capital Master Fund Ltd. 10% owner 2007-02-12 Purchase +360,000,000 $0.01 $3,492,000 429,750,000 I: show line 2 in the form
Open-market purchases · 720,000,000 sh · avg $0.01 · $6,984,000
Loading xslF345X02/v067658_ex.xml…